|
Market Closed -
Toronto S.E.
03:59:32 03/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 16.97 CAD | +1.74% |
|
-1.39% | +10.77% |
| 10-02 | Vance's fraud crackdown may raise costs for US health insurers, enrollees | RE |
| 10-02 | Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms | RE |
Company Valuation: UnitedHealth Group Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 472,941 | 495,373 | 486,945 | 465,535 | 299,026 | 333,816 | - | - |
| Change | - | 4.74% | -1.7% | -4.4% | -35.77% | 11.63% | - | - |
| Enterprise Value (EV) 1 | 495,037 | 514,300 | 519,854 | 513,326 | 349,294 | 380,268 | 375,860 | 372,533 |
| Change | - | 3.89% | 1.08% | -1.26% | -31.95% | 8.87% | -1.16% | -0.89% |
| P/E | 27.8x | 25x | 22.1x | 32.6x | 25x | 20.2x | 17.5x | 15.2x |
| PBR | 6.28x | 6.18x | 5.48x | 5x | 3.18x | 3.34x | 3.05x | 2.83x |
| PEG | - | 1.5x | 1.7x | -0.9x | -1.7x | 0.5x | 1.2x | 1x |
| Capitalization / Revenue | 1.64x | 1.53x | 1.31x | 1.16x | 0.67x | 0.75x | 0.73x | 0.69x |
| EV / Revenue | 1.72x | 1.59x | 1.4x | 1.28x | 0.78x | 0.85x | 0.82x | 0.76x |
| EV / EBITDA | 18.3x | 16.2x | 14.3x | 14.1x | 15x | 12.9x | 11.3x | 10.1x |
| EV / EBIT | 20.7x | 18.1x | 16.1x | 15.9x | 18.4x | 14.8x | 13.2x | 11.5x |
| EV / FCF | 24.9x | 22x | 20.2x | 24.8x | 21.7x | 15.6x | 15x | 14.4x |
| FCF Yield | 4.02% | 4.55% | 4.94% | 4.03% | 4.6% | 6.43% | 6.67% | 6.94% |
| Dividend per Share 2 | 5.6 | 6.4 | 7.29 | 8.18 | 8.73 | 9.192 | 9.401 | 10.06 |
| Rate of return | 1.12% | 1.21% | 1.38% | 1.62% | 2.64% | 2.47% | 2.53% | 2.71% |
| EPS 2 | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 | 18.44 | 21.24 | 24.45 |
| Distribution rate | 31% | 30.2% | 30.6% | 52.7% | 66% | 49.9% | 44.3% | 41.1% |
| Net sales 1 | 287,597 | 324,162 | 371,622 | 400,278 | 447,567 | 447,112 | 460,097 | 487,271 |
| EBITDA 1 | 27,073 | 31,835 | 36,330 | 36,386 | 23,325 | 29,540 | 33,170 | 37,014 |
| EBIT 1 | 23,970 | 28,435 | 32,358 | 32,287 | 18,964 | 25,708 | 28,428 | 32,289 |
| Net income 1 | 17,285 | 20,120 | 22,381 | 14,405 | 12,056 | 16,724 | 19,502 | 22,059 |
| Net Debt 1 | 22,096 | 18,927 | 32,909 | 47,791 | 50,268 | 46,453 | 42,044 | 38,718 |
| Reference price 2 | 502.14 | 530.18 | 526.47 | 505.86 | 330.11 | 371.90 | 371.90 | 371.90 |
| Nbr of stocks (in thousands) | 941,851 | 934,349 | 924,925 | 920,284 | 905,839 | 897,595 | - | - |
| Announcement Date | 19/1/22 | 13/1/23 | 12/1/24 | 16/1/25 | 27/1/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.17x | 0.85x | 12.87x | 2.47% | 334B | ||
| 18.65x | 0.54x | 10.27x | 1.78% | 83.8B | ||
| 10.9x | 0.32x | 7.06x | 2.28% | 71.48B | ||
| 54.23x | 0.33x | 19.1x | 0.95% | 46.63B | ||
| 16.41x | 0.14x | 9.21x | -.--% | 31.12B | ||
| 64.31x | 0.2x | 12.13x | -.--% | 9.87B | ||
| 9.83x | 0.47x | 8.73x | 5.36% | 7.83B | ||
| 77.58x | 0.77x | 28.31x | -.--% | 2.33B | ||
| 19.62x | 1.29x | 7.46x | -.--% | 1.94B | ||
| Average | 32.41x | 0.55x | 12.79x | 1.43% | 65.42B | |
| Weighted average by Cap. | 22.16x | 0.65x | 12.07x | 2.08% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNH Stock
- UNH Stock
- Valuation UnitedHealth Group Incorporated
Select your edition
All financial news and data tailored to specific country editions
















